|
2026 Conference Publication Real-world quality of life, disability, and work productivity outcomes with ustekinumab in moderate-to-severe Crohn's disease: Results from an Australian prospective multicenter observational cohort studyMa, Xiaomin, An, Yoon-Kyo and Begun, Jakob (2026). Real-world quality of life, disability, and work productivity outcomes with ustekinumab in moderate-to-severe Crohn's disease: Results from an Australian prospective multicenter observational cohort study. HOBOKEN: WILEY. |
|
2026 Conference Publication Real-world effectiveness of upadacitinib for Crohn's disease: One-year outcomes from a multicenter cohort examining complex phenotypesGilmore, Robert, Goetz, Naeman, Yeo, Jeremy, Pham, Lily, Fernandes, Richard, Nguyen, Andrew, Vasudevan, Abhinav, Parkash, Nikita, Moore, Gregory, Christmas, Michael, White, Lauren, Subhaharan, Deloshaan, Ramaswamy, Pradeep, Mohsen, Waled, Massouridis, Benjamin, Sparrow, Miles, Lin, Alan, Clark, Nicholas, Ding, Nik, Lo, Sheng, De Cruz, Peter, Thin, Lena, Riley, Maddeson, Connor, Susan Jane, Lee, Adrian, Corte, Crispin, O'Hare, Rosie, Tan, Terrance, Etchegaray, Amirah ... Begun, Jakob (2026). Real-world effectiveness of upadacitinib for Crohn's disease: One-year outcomes from a multicenter cohort examining complex phenotypes. HOBOKEN: WILEY. |
|
2026 Conference Publication Upadacitinib versus oral corticosteroid for induction of remission in ulcerative colitis flares: INDUCE-A prospective, multicenter, open-label studyGilmore, Robert, Goetz, Naeman, An, Yoon-Kyo and Begun, Jakob (2026). Upadacitinib versus oral corticosteroid for induction of remission in ulcerative colitis flares: INDUCE-A prospective, multicenter, open-label study. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2026, Perth, WA, Australia, 28–31 August 2026. Richmond, VIC, Australia: John Wiley & Sons. |
|
2026 Conference Publication Evaluation of transmural healing in patients with moderately to severely active Crohn's disease shows early efficacy of vedolizumab: VECTORS week 14 interim analysisSparrow, Miles, Jairath, Vipul, Vuyyuru, Sudheer K., Ma, Christopher, Zou, Guangysong, Neustifter, Blue, Agboton, Christian, Bautista, Itzel Romo, Wu, Jingang Jackie, Jiang, Hongyu Jeanne, Allocca, Mariangela, An, Yoon-Kyo, Begun, Jakob, Bryant, Robert, Danese, Silvio, Dubinsky, Marla C., Freire, Marcelo, Novak, Kerri L., Panaccione, Remo, Pudipeddi, Aviv, Rubin, David T., Sands, Bruce E., Taylor, Stuart A., Gecse, Krisztina B., Maaser, Christian, Feagan, Brian G. and Wilkens, Rune (2026). Evaluation of transmural healing in patients with moderately to severely active Crohn's disease shows early efficacy of vedolizumab: VECTORS week 14 interim analysis. HOBOKEN: WILEY. |
|
2026 Conference Publication Novel Bacteroides cellulosilyticus strain produces a small anti-inflammatory bioactive with therapeutic potential for inflammatory bowel diseaseMurtaza, Nida, Giri, Rabina, Schooth, Lauren, Salim, Angela, Capon, Rob, Morrison, Mark and Begun, Jakob (2026). Novel Bacteroides cellulosilyticus strain produces a small anti-inflammatory bioactive with therapeutic potential for inflammatory bowel disease. Gastroenterological Society of Australia (GESA) Australian Gastroenterology Week (AGW) 2026, Perth, WA Australia, 28-31 August 2026. Richmond, VIC Australia: John Wiley & Sons. |
|
2026 Conference Publication Challenging the indolent paradigm: Elderly acute severe ulcerative colitis has outcomes similar to younger cohortsKarunadasa, Hirannya, Mohamedrashed, Mustafa, O'Connor, Ronan, Fernandes, Richard Gareth, Ruddick-Collins, Leonie, Brownson, Anthony Robert, Ngoi, Benjamin, Haifer, Craig, Swe, Ei, Wright, Emily K., Mahy, Gillian, Moore, Gregory, Zhang, Jennifer, Lynch, Kate, Gazelakis, Kathryn, Rice, Katie, Bracken, Lucy Mary Lilian, Garg, Mayur, Schultz, Michael, Clark, Nicholas, Gilmore, Robert, Kashkooli, Soleiman, Schildkraut, Tamar, Begun, Jakob, An, Yoon-Kyo, Srinivasan, Ashish and Vasudevan, Abhinav (2026). Challenging the indolent paradigm: Elderly acute severe ulcerative colitis has outcomes similar to younger cohorts. HOBOKEN: WILEY. |
|
2026 Conference Publication Prescribing patterns and persistence of advanced therapies in people with ulcerative colitis who are bio-experienced: Insights from the Crohn's Colitis Care registryWu, Rodger, Ghali, Mark, Wilson, William, Caquilpan, Victor, Rivas, Consuelo, Lynch, Kate, Haifer, Craig, Walker, Gareth, Radford-Smith, Graham, Lawrance, Ian, Begun, Jakob, Wark, Gabrielle, Verdon, Christine, Andrews, Jane Mary, Ghaly, Simon and Connor, Susan Jane (2026). Prescribing patterns and persistence of advanced therapies in people with ulcerative colitis who are bio-experienced: Insights from the Crohn's Colitis Care registry. HOBOKEN: WILEY. |
|
2026 Conference Publication Serum calprotectin has limited utility as a biomarker of mucosal inflammation and remission in vedolizumab-treated ulcerative colitis: A post-hoc analysis of the VIEWS trialPajes, Nico, Pudipeddi, Aviv, Paramsothy, Sudarshan, Kariyawasam, Viraj, Gu, Bonita, Louie, Gary, Rayamajhee, Binod, Chami, Belal, Paramsothy, Ramesh, Ghaly, Simon, Haifer, Craig, An, Yoon-Kyo, Begun, Jakob, Connor, Susan Jane, Corte, Crispin, Ward, Mark, De Cruz, Peter, Fung, Caroline Lan-San, Redmond, Diane, Kermeen, Melissa, Chan, Webber, Mourad, Fadi H. and Leong, Rupert (2026). Serum calprotectin has limited utility as a biomarker of mucosal inflammation and remission in vedolizumab-treated ulcerative colitis: A post-hoc analysis of the VIEWS trial. HOBOKEN: WILEY. |
|
2026 Conference Publication Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMWu, Rodger, Caquilpan, Victor, Wilson, William E., Lynch, Kate D., Ng, Watson, Lawrance, Ian C., Radford-Smith, Graham, Walker, Gareth, Begun, Jakob, Moore, Gregory, Ghaly, Simon, Dutt, Shoma, Giles, Edward, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)02588-6 |
|
2026 Conference Publication TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN'S DISEASE COHORT: INSIGHTS FROM THE CROHN'S COLITIS CURE DATA INSIGHTS PROGRAMRiley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN'S DISEASE COHORT: INSIGHTS FROM THE CROHN'S COLITIS CURE DATA INSIGHTS PROGRAM. Digestive Disease Week (DDW), Chicago Il, May 02-05, 2026. PHILADELPHIA: W B SAUNDERS CO-ELSEVIER INC. |
|
2026 Conference Publication Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMWu, Rodger, Su, Wai Kin, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Wark, Gabrielle, Lawrance, Ian C., Begun, Jakob, Haifer, Craig, Radford-Smith, Graham, Walker, Gareth, Shahzad, Asif, Giles, Edward, Dutt, Shoma, Connor, Susan J. and Andrews, Jane (2026). Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)02784-8 |
|
2026 Conference Publication Mo1597 Prescribing patterns and persistence of advanced therapies in people with Crohn’s disease with prior advanced therapy: Crohn’s colitis cure data insights programGhali, Mark, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Haifer, Craig, Ng, Watson, Lynch, Kate D., Lawrance, Ian C., Begun, Jakob, Walker, Gareth, Radford-Smith, Graham, Shahzad, Asif, Boyapati, Ray, Verdon, Christine, Connor, Susan J., Andrews, Jane and Ghaly, Simon (2026). Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1204. doi: 10.1016/s0016-5107(26)02967-6 |
|
2026 Conference Publication Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMWu, Rodger, Ghali, Mark, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Lynch, Kate D., Wark, Gabrielle, Haifer, Craig, Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Lawrance, Ian C., Verdon, Christine, Ghaly, Simon, Andrews, Jane and Connor, Susan J. (2026). Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)03029-5 |
|
2026 Conference Publication Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMRiley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)02786-1 |
|
2026 Conference Publication Sa1578 Divided by distance: insights into regional disparities in inflammatory bowel disease care across Australia from the Crohn’s colitis cure data insights programWu, Rodger, Caquilpan, Victor, Wilson, William E., Lynch, Kate D., Ng, Watson, Lawrance, Ian C., Radford-Smith, Graham, Walker, Gareth, Begun, Jakob, Moore, Gregory, Ghaly, Simon, Dutt, Shoma, Giles, Edward, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Sa1578 DIVIDED BY DISTANCE: INSIGHTS INTO REGIONAL DISPARITIES IN INFLAMMATORY BOWEL DISEASE CARE ACROSS AUSTRALIA FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-992. doi: 10.1016/s0016-5107(26)02519-8 |
|
2026 Conference Publication Mo1590 Prescribing patterns and persistence of advanced therapies in people with ulcerative colitis who are bio-experienced: Crohn’s colitis cure data insights programWu, Rodger, Ghali, Mark, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Lynch, Kate D., Wark, Gabrielle, Haifer, Craig, Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Lawrance, Ian C., Verdon, Christine, Ghaly, Simon, Andrews, Jane and Connor, Susan J. (2026). Mo1590 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH ULCERATIVE COLITIS WHO ARE BIO-EXPERIENCED: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1201. doi: 10.1016/s0016-5107(26)02960-3 |
|
2026 Conference Publication Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAMGhali, Mark, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Rivas, Consuelo, Haifer, Craig, Ng, Watson, Lynch, Kate D., Lawrance, Ian C., Begun, Jakob, Walker, Gareth, Radford-Smith, Graham, Shahzad, Asif, Boyapati, Ray, Verdon, Christine, Connor, Susan J., Andrews, Jane and Ghaly, Simon (2026). Mo1597 PRESCRIBING PATTERNS AND PERSISTENCE OF ADVANCED THERAPIES IN PEOPLE WITH CROHN’S DISEASE WITH PRIOR ADVANCED THERAPY: CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Elsevier BV. doi: 10.1016/s0016-5085(26)03036-2 |
|
2026 Conference Publication 536 UPADACITINIB VS CORTICOSTEROID FOR THE MANAGEMENT OF ULCERATIVE COLITIS FLARES: A MULTICENTRE PROSPECTIVE STUDYGilmore, Robert, An, Yoon-Kyo and Begun, Jakob (2026). 536 UPADACITINIB VS CORTICOSTEROID FOR THE MANAGEMENT OF ULCERATIVE COLITIS FLARES: A MULTICENTRE PROSPECTIVE STUDY. Digestive Disease Week (DDW), Chicago Il, May 02-05, 2026. PHILADELPHIA: Elsevier BV. doi: 10.1016/s0016-5085(26)02356-5 |
|
2026 Conference Publication Su1577 Real-world trends in subcutaneous and intravenous infliximab and vedolizumab use in inflammatory bowel disease from 2021 to 2024: Insights from Crohn’s colitis cure data insights programWu, Rodger, Su, Wai Kin, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Wark, Gabrielle, Lawrance, Ian C., Begun, Jakob, Haifer, Craig, Radford-Smith, Graham, Walker, Gareth, Shahzad, Asif, Giles, Edward, Dutt, Shoma, Connor, Susan J. and Andrews, Jane (2026). Su1577 REAL-WORLD TRENDS IN SUBCUTANEOUS AND INTRAVENOUS INFLIXIMAB AND VEDOLIZUMAB USE IN INFLAMMATORY BOWEL DISEASE FROM 2021 TO 2024: INSIGHTS FROM CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1081. doi: 10.1016/s0016-5107(26)02715-x |
|
2026 Conference Publication Su1579 Timing and predictors of bowel resection in a large Crohn’s disease cohort: Insights from the Crohn’s colitis cure data insights programRiley, Maddeson, Wu, Rodger, Wilson, William E., Caquilpan, Victor, Lynch, Kate D., Ng, Watson, Ghaly, Simon, Gearry, Richard, Schultz, Michael, Lawrance, Ian C., Walker, Gareth, Radford-Smith, Graham, Begun, Jakob, Shahzad, Asif, Dutt, Shoma, Moore, Gregory, Verdon, Christine, Andrews, Jane and Connor, Susan J. (2026). Su1579 TIMING AND PREDICTORS OF BOWEL RESECTION IN A LARGE CROHN’S DISEASE COHORT: INSIGHTS FROM THE CROHN’S COLITIS CURE DATA INSIGHTS PROGRAM. Gastrointestinal Endoscopy, 103 (5), S-1082. doi: 10.1016/s0016-5107(26)02717-3 |
